Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2575 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- HLA-B Antibody
- Antibody type
- Monoclonal
- Antigen
- Normal human peripheral blood lymphocytes were used as the immunogen for the HLA-B antibody.
- Description
- Protein G purified antibody
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- JOAN-1
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the HLA-B antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references Evaluation of CD20, CD22, and HLA-DR targeting for radioimmunotherapy of B-cell lymphomas.
Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
Comparison of surface HLA class I levels in squamous cell carcinoma cell lines of the head and neck.
Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
Expression of HLA class I/II antigens and T cell immune response in human neuroendocrine tumors of the pancreas.
Molecular analysis of MHC-class-I alterations in human tumor cell lines.
Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors.
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
Pagel JM, Pantelias A, Hedin N, Wilbur S, Saganic L, Lin Y, Axworthy D, Hamlin DK, Wilbur DS, Gopal AK, Press OW
Cancer research 2007 Jun 15;67(12):5921-8
Cancer research 2007 Jun 15;67(12):5921-8
Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
Ryschich E, Nötzel T, Hinz U, Autschbach F, Ferguson J, Simon I, Weitz J, Fröhlich B, Klar E, Büchler MW, Schmidt J
Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Jan 15;11(2 Pt 1):498-504
Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Jan 15;11(2 Pt 1):498-504
Comparison of surface HLA class I levels in squamous cell carcinoma cell lines of the head and neck.
Mandic R, Lieder A, Sadowski M, Peldszus R, Werner JA
Anticancer research 2004 Mar-Apr;24(2B):973-9
Anticancer research 2004 Mar-Apr;24(2B):973-9
Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
Ryschich E, Cebotari O, Fabian OV, Autschbach F, Kleeff J, Friess H, Bierhaus A, Büchler MW, Schmidt J
Tissue antigens 2004 Dec;64(6):696-702
Tissue antigens 2004 Dec;64(6):696-702
Expression of HLA class I/II antigens and T cell immune response in human neuroendocrine tumors of the pancreas.
Ryschich E, Autschbach F, Eisold S, Klar E, Buchler MW, Schmidt J
Tissue antigens 2003 Jul;62(1):48-54
Tissue antigens 2003 Jul;62(1):48-54
Molecular analysis of MHC-class-I alterations in human tumor cell lines.
Ruiz-Cabello F, Perez-Ayala M, Gomez O, Redondo M, Concha A, Cabrera T, Garrido F
International journal of cancer. Supplement = Journal international du cancer. Supplement 1991;6:123-30
International journal of cancer. Supplement = Journal international du cancer. Supplement 1991;6:123-30
Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
Redondo M, Ruiz-Cabello F, Concha A, Cabrera T, Pérez-Ayala M, Oliva MR, Garrido F
Cancer research 1991 May 1;51(9):2463-8
Cancer research 1991 May 1;51(9):2463-8
Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors.
Peña J, Alonso C, Solana R, Serrano R, Carracedo J, Ramirez R
European journal of immunology 1990 Nov;20(11):2445-8
European journal of immunology 1990 Nov;20(11):2445-8
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
López-Nevot MA, Esteban F, Ferrón A, Gutiérrez J, Oliva MR, Romero C, Huelin C, Ruiz-Cabello F, Garrido F
British journal of cancer 1989 Feb;59(2):221-6
British journal of cancer 1989 Feb;59(2):221-6
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- SDS-PAGE Analysis of Purified, BSA-Free HLA-B Antibody (clone JOAN-1 ). Confirmation of Integrity and Purity of the Antibody.